Stephane Pelliet

Commercial Excellence and Route-To-Market Strategy | Life science, Pharma, Consumer Health, FMCG | B2B, B2C | Avantor, Zuellig Pharma, Novartis, Danone | Asia-Europe

๐Ÿ“ Singapore๐Ÿ”„ Updated September 2026๐Ÿ’ผ 1 investments๐Ÿ“… 5 years investing๐Ÿ—“ Last invested Feb 2021
VC๐ŸŒ Singapore
1
Total investments
0
Early stage
1
Mid stage
0
Late stage
5y
Years active

Portfolio

1 investments ยท sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor & Advisor
Feb 2021
EthAum Venture Partners leverages its GTM ecosystem (SI/ Channel Partners, CXO Network) and GTM activities (Roadshows, Thought Leaderships, Roast Sessions) to solve startups hardest and most critical challenge, which is customer acquisition and new market expansion. We are a Deep Tech Revenue Scaler and investor with 100+ portfolio startups from Seed to Series B stages serving to Fortune 1,000 organizations globally. We run the Zero BS Revenue Scaler Program, which helps Post-Revenue, B2B startups secure pilots and funding. We stay away from startup101 or generic workshops since internet is full of that content delivered by worlds best CEOs, investors and founders.
Experience ยท 1 entries
All (1)
Investments (1)
2021
Investor & Advisor
Feb 2021
EthAum Venture Partners leverages its GTM ecosystem (SI/ Channel Partners, CXO Network) and GTM activities (Roadshows, Thought Leaderships, Roast Sessions) to solve startups hardest and most critical challenge, which is customer acquisition and new market expansion. We are a Deep Tech Revenue Scaler and investor with 100+ portfolio startups from Seed to Series B stages serving to Fortune 1,000 organizations globally. We run the Zero BS Revenue Scaler Program, which helps Post-Revenue, B2B startups secure pilots and funding. We stay away from startup101 or generic workshops since internet is full of that content delivered by worlds best CEOs, investors and founders.